Fox Business - The Power to Prosper
Search Site

Allergan

SEC Chair Mary Jo White critical of Ackman’s Allergan trades

Fox Business Senior Correspondent Charlie Gasparino on SEC Chair Mary Jo White’s critical comments against Bill Ackman and his Allergan trades.

Read More

  1. 2014: The year of the activist

    David Benoit of The Wall Street Journal discusses activist investor activity in 2014.

  2. Investing for the New Year

    S&P Capital IQ Senior Director Rich Peterson, Veracruz Founder Steve Cortes and Morgan Creek Capital Management CEO Mark Yusko discuss how to prepare your portfolio for 2015.

  3. A great year for M&A

    Dana Mattioli of The Wall Street Journal discusses 2014 M&A volume.

  4. 86M unemployed Americans don’t want a job?

    Capitalistpig Asset Management’s Jonathan Hoenig and FBN’s Liz MacDonald and Tracy Byrnes on the number of unemployed Americans who do not want to work and the record M&A activity.

  5. Inside the Allergan , Actavis deal

    Wall Street Journal Reporter David Benoit weighs in on the $66 billion deal for Activis to acquire Allergan .

  6. Ackman makes $2B bet on animal health

    David Benoit and Liz Hoffman of The Wall Street Journal on activist investor Bill Ackman’s new stake in animal health company Zoetis.

  7. Salix’s market-cap vaporizing

    FBN’s Liz MacDonald on Salix shares dropping.

  8. Darden investors elect full Starboard slate

    Christopher Davis of Kleinberg Kaplan and David Benoit of The Wall Street Journal discuss Starboards victory in replacing Darden’s board.

  9. Ackman threatens to sue Allergan over Salix deal

    David Benoit of The Wall Street Journal breaks down the latest on the fight to take over Allergan .

  10. Allergan in talks to buy Salix

    Wall Street Journal reporters David Benoit and Liz Hoffman on Allergan ’s efforts to buy Salix to ward off Valeant’s hostile bid.

  11. Shooter Jennings sings ‘She Thinks I Still Care’

    Musician Shooter Jennings sings ‘She Thinks I Still Care’ on Imus.

  12. The inversion play

    FBN’s Liz MacDonald on hedge funds’ inversion push.

  1. What’s next for Bill Ackman?

    Pershing Square CEO Bill Ackman discusses his outlook for the probe, why he reinvested in Valiant and how he thinks hedge funds impact the average investor.

  2. What Bill Ackman Has His Eye on Now

    Pershing Square founder and CEO Bill Ackman on the 2015 Harbor Investment Conference and why activist investors are important for corporate America.

  3. One-on-one with Bill Ackman

    FBN’s Deidre Bolton talks to Pershing Square Capital Founder and CEO Bill Ackman about the role of the activist investor.

  4. Actavis CEO talks dealflow

    Actavis CEO Brenton Saunders says deal-making strategically supports the company’s goal of dominating the pharma business.

  5. The worst and best predictions for 2015 markets

    Forbes contributor Rick Ungar, Fort Pitt Capital V.P. Kim Forrest and FBN’s Cheryl Casone on the 2015 outlook for interest rates, the markets and investing like the one percent.

  6. How should the U.S. react to the Sony cyber-attack?

    Fox News National Security Analyst KT McFarland and FBN’s Liz MacDonald weigh in on ways to increase U.S. cybersecurity, the best ways to retaliate in a cyber-war and the release of Guantanamo Bay prisoners.

  7. 2014 stellar year for deals on Wall Street

    As stock markets surged to record highs this year, investors grew hungrier for opportunities to make deals, pushing M&A activity to pre-recession levels.

‹ Prev12345Next ›
Freebase CC-BY
Source: Allergan on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL